BioMarin Pharmaceutical's CEO is still optimistic about FDA approval of its Duchenne muscular dystrophy drug, drisapersen, despite FDA concerns» Read More
The United States has asked Greece to deny Russia the use of its airspace for supply flights to Syria, a Greek official said on Monday.
Dick Bove, the vice president of equity research at Rafferty Capital Markets, has heaped pressure on Bank of America.
Congress returns, facing only 12 days to find a compromise to keep the government open and vote on Iran, among other issues. The NYT reports.
No advisor compensation model is perfect, and all pose conflicts of interest investors need to be aware of and advisors need to manage.
Concordia Healthcare said it would buy Amdipharm Mercury for $1.9 billion to expand its portfolio of drugs aimed at treating rare diseases.
U.S. small business confidence rose modestly in August, suggesting the economy continued to grow at a steady clip halfway through the third quarter.
Here, in ascending order, are the 10 best college towns for retirees.
Volatility has soared in the last month, and some traders say there could be a lot more to come.
Apple faces a new dilemma on how to hide the fact that its new iPhone costs upward of $650 — and in some cases close to $1,000.
Here are eight kitchen remodeling projects that cost $500 or less.
The economy added 173,000 jobs in August, lower than expected, while the unemployment rate fell to 5.1 percent.
Tweak your Facebook settings to make sure you're sharing the right amount, with the right people. USA Today reports.
Facebook-owned messaging app WhatsApp now has 900 million monthly active users, its founder Jan Koum wrote on a Facebook post Thursday.
The U.S. Labor Department said Friday that the unemployment rate dropped to 5.1 percent in August, but does that rate tell the real story?
"It's time to align our monetary policy with economic progress," the Richmond Fed chief said, adding that the labor market no longer warrants zero rates.
Markets need to calm down for the Fed to pull the trigger on the first interest rate hike in more than nine years, Ethan Harris says.
Worried about further selling? Here's a simple strategy to protect your portfolio.
Short sellers are continuing to target biotechnology stocks as one of the frothiest sectors in US equities staggers after a bruising August.
Saudi King Salman will visit President Obama on Friday to discuss the Iran nuclear deal, and he's doing it in style, reports USA Today.
Tennis is supposed to be a young person's sport, but this year's U.S. Open could crown two of the oldest winners in its history.
Get the best of CNBC in your inbox
Mark Zuckerberg isn't the kind of Californian who normally takes paid paternity leave. Here's who is.
Blue Bell will release another ice cream flavor, the sixth since the company recalled millions of products following listeria contamination.
One unlikely club is making a nice profit during the two-week deer season in the backwoods of Michigan's Upper Peninsula.
Two high profile drug makers are coming under increasing pressure over the prices of key drugs. CNBC’s Meg Tirrell reports the details.
What can Bear Stearns’ bullish call on Enron teach investors? Will Ortel of the CFA Institute discusses with Brian Sullivan.
A new study suggests that hedge funds are actually decent at picking stocks. The author of that study, Harvard Ph.D. candidate Jonathan Rhinesmith, discusses with Brian Sullivan.